<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Radiat Oncol</journal-id>
      <journal-title-group>
        <journal-title>Radiation Oncology (London, England)</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1748-717X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20122250</article-id>
      <article-id pub-id-type="pmc">2827478</article-id>
      <article-id pub-id-type="publisher-id">1748-717X-5-7</article-id>
      <article-id pub-id-type="doi">10.1186/1748-717X-5-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>de Vries</surname>
            <given-names>Iris AC</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>i.devries@student.maastrichtuniversity.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>van Acht</surname>
            <given-names>Marjolein MS</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>marjolein.v.acht@catharina-ziekenhuis.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Demeyere</surname>
            <given-names>Thomas BJ</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>t.demeyere@pamm.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Lybeert</surname>
            <given-names>Marnix LM</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>marnix.lybeert@catharina-ziekenhuis.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>de Zoete</surname>
            <given-names>Jean-Paul</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jean-paul.d.zoete@catharina-ziekenhuis.nl</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A6">
          <name>
            <surname>Nieuwenhuijzen</surname>
            <given-names>Grard AP</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>achgnn@cze.nl</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands</aff>
      <aff id="I2"><label>2</label>Department of Pathology, Catharina Hospital, Eindhoven, The Netherlands</aff>
      <aff id="I3"><label>3</label>Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands</aff>
      <pub-date pub-type="collection">
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>2</month>
        <year>2010</year>
      </pub-date>
      <volume>5</volume>
      <fpage>7</fpage>
      <lpage>7</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>9</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>2</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2010 de Vries et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>de Vries et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.ro-journal.com/content/5/1/7"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Castleman disease (CD) is a rare benign disorder characterised by hyperplasia of lymphoid tissue that may develop at a single site or throughout the body. The etiology of this disorder is unclear, although the histopathological presentation can be differentiated into a hyaline vascular variant, a plasma cell variant and a mixed variant. Clinically, it has been recorded that 3 manifestations of CD are characterized: a localized unicentric type, a generalized multicentric type and a mixed form. Surgery remains the main treatment for resectable unicentric CD, since removal of the large node is possible without further complications. No consensus has been reached concerning the most adequate treatment for irresectable unicentric CD.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Case report of a 67 year old woman.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>This report, describes the case of a 67-year-old woman with unicentric Castleman disease located in the right lower abdomen. The patient had symptoms of fatigue, dyspnoea and pain in the right lower abdomen. Computed tomography (CT)- examination revealed a tumour, which had grown to form a close relationship with the common iliac vessels and the sacral bone. A Laparotomy procedure revealed that the tumour was an irresectable mass. Neo-adjuvant radiotherapy (40 Gy) was administered in order to downsize the tumour. Six weeks later a new CT-scan revealed a major reduction of the tumour, which enabled a successful radical resection of the tumour to be performed. Histopathological analysis of the tumour showed the hyaline vascular type of CD.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Neo-adjuvant radiotherapy should be considered in case of an irresectable unicentric CD.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>In 1954, Benjamin Castleman described an unusual benign disorder that was characterized by hyperplasia of lymphoid tissue [<xref ref-type="bibr" rid="B1">1</xref>]. A couple of years later, Castleman et al [<xref ref-type="bibr" rid="B2">2</xref>] published more cases with benign massive growth of lymph nodes that is commonly referred to as Castleman's disease (CD). Flendrig et al [<xref ref-type="bibr" rid="B3">3</xref>] categorised two main types and one mixed variant of CD. Keller et al [<xref ref-type="bibr" rid="B4">4</xref>] defined these histopathological different patterns.</p>
      <p>The first being a hyaline vascular type (HV), characterized by lymphoid follicular hyperplasia with involuted germinal centres, which are partly or totally replaced by deposit of hyaline material and transfixed by a radially penetrating vessel, characterized as a 'lolly pop' structure. The second variant was defined as the plasma cell type (PC) with a follicular hyperplasia of hyperplastic, large germinal centres in which the interfollicular areas were occupied by large sheets of plasma cells.</p>
      <p>Clinically a broad spectrum of manifestations of CD are described, ranging from an asymptomatic localized lymphadenopathy to a severe symptomatic multifocal or generalized lymphadenopathy [<xref ref-type="bibr" rid="B5">5</xref>]. A commonly used system to classify the heterogeneity of CD was proposed by McCarty et al in 1995 [<xref ref-type="bibr" rid="B6">6</xref>]. This made a distinction between the unicentric and the multicentric forms of disease. This classification correlates quite well with the histopathologically variants. As the HV type is mostly unicentric and the PC type and the mixed variant seem to be mostly multicentric [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>CD has to be treated because of its progressive course associated with local involvement of surrounding structures or because of the systemic effects associated with the multicentric form such as fever, weight loss, excessive sweating, hemolytic anaemia, splenomegaly, oedema and neuropathy.</p>
      <p>CD can also be associated with HIV infection, POEMS syndrome, amyloidosis, renal insufficiency and increased risk of lymphoma [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>], these conditions necessitate diagnostic and therapeutic intervention.</p>
      <p>Surgery is considered to be the most adequate therapy for unicentric resectable cases of CD, as it seems to be curative in almost all of the cases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Radiotherapy has also been described as a definitive treatment, however with a variable response rate [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B30">30</xref>].</p>
      <p>No consensus has been reached concerning the most adequate treatment for irresectable CD. To our knowledge, neo-adjuvant radiotherapy to downsize primary irresectable CD in order to achieve a radical surgical resection has not been described yet. This paper reviews the associated literature concerning the treatment of CD and describes a case history of an irresectable unicentric localisation of CD which was treated with neo-adjuvant radiotherapy and subsequent radical resection.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Case presentation</title>
        <p>A 67-year-old woman with a history of hyperthyroidism, proptosis and anaemia was referred to the internal medicine department with complaints of weight loss, fatigue, dyspnea and pain in the right lower abdomen. Physical examination revealed a painful palpable mass in the right lower quadrant of the abdomen.</p>
        <p>Ultrasonography of the abdomen showed a multicystic, solid structure in the right lower abdomen. Subsequent Computed Tomography (CT) imaging of the abdomen showed right ventrally of the body of the first sacral vertebrum a partly solid, partly cystic tumour of 71 &#xD7; 51 mm with oedematous infiltration of the surrounding adipose tissue and a close relationship with the common iliac artery and vein (figure <xref ref-type="fig" rid="F1">1A</xref>). Since the radiological aspect was initially presumed to be indicative of ovarian cancer, the patient was referred for gynaecological examination. Transvaginal ultrasound showed a polycystic structure on the right side. CA125 was normal. The patient underwent a staging laparotomy by the gynaecologist, revealing a normal uterus, normal ovaries and a fixed retroperitoneal tumour located to the right side of the aortic bifurcation. A surgeon oncologist was consulted, and because of the fixation and close relationship of the tumour to the iliac vessels and sacral bone, the tumour was regarded as primary irresectable and only an incisional biopsy was performed to obtain material for histological examination. Histopathology from the specimen revealed lymphoid hyperplasia, atrophic germinal centers and radialy penetrating vessels (lollypop phenomenon) as seen in the HV variant of CD, (figure <xref ref-type="fig" rid="F2">2</xref>). A subsequent positron emission tomogram (PET)-scan revealed no signs of disseminated disease. There were no laboratory abnormalities and the HIV test turned out to be negative. Since the tumour was regarded irresectable, neo-adjuvant radiotherapy was proposed in order to downsize the tumour to achieve a radical surgical excision. Neo-adjuvant radiotherapy was delivered by means of a 4-field technique to a dose of 40 Gy in 20 fractions of 2 Gy. Six weeks later a CT-scan, revealed a major downsizing with a maximal diameter of the tumour of 47 mm, which was initially 72 mm (figure <xref ref-type="fig" rid="F1">1B</xref>). A subsequent laparotomy revealed a mobile tumour and a radical resection was performed without complications. An intraoperative boost (IORT) of 10 Gy was applied to the presacral resection surface. The patient recovered without complications and final histology showed a cystic residual localisation of CD of the HV type with free resection margins. At present, two years and 3 months after resection of the tumour no signs of recurrence have been detected.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>A: Computed Tomography (CT) of the abdomen showing the tumour and its relationship with the sacral vertebrum, the adipose tissue and the common iliac artery and vein, before neo-adjuvant radiotherapy</bold>. <bold><bold>B: </bold>Computed Tomography (CT) of the abdomen showing the marked downsizing of the tumour, after neo-adjuvant radiotherapy.</bold></p>
          </caption>
          <graphic xlink:href="1748-717X-5-7-1"/>
        </fig>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Histopathology showing lymphoid hyperplasia, atrophic germinal centers and radialy penetrating vessels (lollypop phenomenon) as seen in the HV variant of CD</bold>.</p>
          </caption>
          <graphic xlink:href="1748-717X-5-7-2"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>This report documents a unique case of a primary irresectable case of the HV unicentric type of CD which was treated with neoadjuvant radiotherapy and subsequent successful radical resection. To our knowledge, there is no report in the literature describing neoadjuvant radiotherapy as part of the treatment of unicentric CD.</p>
      <p>The etiology of Castleman's Disease is unknown. However, CD is associated with other disorders such as HIV infection, POEMS syndrome, amyloidosis, renal insufficiency and increased risk of lymphoma [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>]. Therefore specific systemic therapy related to the associated disorder is indicated. There is no consensus yet concerning the most adequate treatment for CD. Surgery is considered to be the most adequate therapy for unicentric cases of CD as it seems to be curative in most of the cases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Various strategies have been described in case of irresectable unicentric CD ranging from primary radiotherapy, incomplete resection [<xref ref-type="bibr" rid="B10">10</xref>] and chemotherapy [<xref ref-type="bibr" rid="B31">31</xref>].</p>
      <p>Primary radiotherapy has been described in numerous case reports and small case series as one of the strategies for the treatment of both unicentric and multicentric forms of CD. Keller et al [<xref ref-type="bibr" rid="B4">4</xref>] however described that in 4 cases primary radiotherapy had only a minimal effect and concluded that radiotherapy alone was not effective. However, several cases have been reported with significant responses to primary radiotherapy, for the unicentric as well as for the multicentric form of CD [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Table <xref ref-type="table" rid="T1">1</xref>, presents an overview of all studies that have evaluated the use of primary radiotherapy in CD, both for unicentric and multicentric disease, with doses ranging from 12 to 50 Gy [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Responses to primary radiotherapy for the treatment of both forms of CD ranged from no response to a complete response. Nevertheless, 88% of all CD patients treated with radiotherapy showed a response, of which 43,8% showed a complete response.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Summary of reports describing patients with CD treated with primary radiotherapy</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left">Reference</th>
              <th align="center">Number of patients<break/>(n = 32)</th>
              <th align="center">Histopathology</th>
              <th align="center">Type</th>
              <th align="center">Dose</th>
              <th align="center">Response</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Fitzpatrick et al. (1968)</td>
              <td align="center">1</td>
              <td align="center">-</td>
              <td align="center">Unicentric</td>
              <td align="center">4500</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td/>
              <td align="center">1</td>
              <td align="center">-</td>
              <td align="center">Unicentric</td>
              <td align="center">-</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Keller et al. (1972)</td>
              <td align="center">4</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">1800-4300</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Emson et al. (1973)</td>
              <td align="center">1</td>
              <td align="center">-</td>
              <td align="center">-</td>
              <td align="center">3500</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Nordstrom et al. (1978)</td>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Unicentric</td>
              <td align="center">2700</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Nordstrom et al. (1978)</td>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Unicentric</td>
              <td align="center">2700</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td/>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Multicentric</td>
              <td align="center">1500</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Gaba et al. (1978)</td>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Multicentric</td>
              <td align="center">4500</td>
              <td align="center">NR</td>
            </tr>
            <tr>
              <td align="left">Weisenburger et al. (1979)</td>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Unicentric</td>
              <td align="center">2700</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Marti et al. (1983)</td>
              <td align="center">1</td>
              <td align="center">M</td>
              <td align="center">Multicentric</td>
              <td align="center">1200</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Stokes et al. (1985)</td>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Unicentric</td>
              <td align="center">3939</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Sethi et al (1990)</td>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4500</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Massey et al. (1991)</td>
              <td align="center">1</td>
              <td align="center">M</td>
              <td align="center">Unicentric</td>
              <td align="center">3040</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Latz et al. (1992)</td>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4000</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Veldhuis et al. (1996)</td>
              <td align="center">1</td>
              <td align="center">PC</td>
              <td align="center">Unicentric</td>
              <td align="center">4000</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Bowne et al. (1999)</td>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4500</td>
              <td align="center">NR</td>
            </tr>
            <tr>
              <td align="left">Chronowski et al.(2001)</td>
              <td align="center">4</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4000</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td/>
              <td align="center">4</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">3960</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td/>
              <td align="center">2</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">3960</td>
              <td align="center">PR</td>
            </tr>
            <tr>
              <td align="left">Neuhof and Debus (2006)</td>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4000-5000</td>
              <td align="center">NR</td>
            </tr>
            <tr>
              <td/>
              <td align="center">1</td>
              <td align="center">HV</td>
              <td align="center">Unicentric</td>
              <td align="center">4000-5000</td>
              <td align="center">CR</td>
            </tr>
            <tr>
              <td align="left">Neuhof and Debus (2006)</td>
              <td align="center">1</td>
              <td align="center">M</td>
              <td align="center">Unicentric</td>
              <td align="center">4000-5000</td>
              <td align="center">NR</td>
            </tr>
            <tr>
              <td align="left">All Reports</td>
              <td align="center">32</td>
              <td/>
              <td/>
              <td/>
              <td align="center">CR: 14/32:43,8%<break/>PR: 14/32:43,8%<break/>NR: 4/32:12,4%</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>PC (plasma cell type); HV (hyaline vascular type); M (mixed HV and PC type); PR (partial response);</p>
          <p>CR (complete response); NR (non response);</p>
        </table-wrap-foot>
      </table-wrap>
      <p>With respect to the dose of radiotherapy, no correlation can be observed between dose and response. Most patients were treated with a dose between 40 and 50 Gy, however patients with a complete response received a dose between 12 Gy and 50 Gy.</p>
      <p>The evidence in the current literature reveals that radical surgery results in excellent rates of cure [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. Also the literature reports excellent response rates with primary radiotherapy (table <xref ref-type="table" rid="T1">1</xref>). Therefore it was concluded that, in case of an irresectable presentation of unicentric CD, surgery after neoadjuvant radiotherapy was a possible strategy. This case illustrates that this hypothesis was successful and should be considered as a strategy in case of irresectable unicentric disease. The question remains which policy should be followed in case of a complete radiologic response. Although merely speculative, a wait and see policy with regular radiological follow-up could be a reasonable strategy in case of no systemic symptoms, since most reports describe unicentric CD as a slowly progressive disease, which does not metastasize. In the case where a recurrence of residual disease is found, a resection in an early stage could still be performed. In that case we propose a frequent follow up, using CT scanning every six months, since unicentric CD is a slowly progressive disease. In case of a partial response to primary radiotherapy, we suggest that surgical resection is strongly recommended, since radical surgery can potentially cure unicentric CD.</p>
      <p>Surgery was performed six weeks after the last radiotherapy dose. The rationale for this interval is based on the experience gained from treatments with other neoadjuvant strategies in solid tumours [<xref ref-type="bibr" rid="B36">36</xref>].</p>
      <p>Different types of therapy have been described for the treatment of patients with multicentric CD. However the treatment strategy for this variant of CD is not within the scope of this article. Nevertheless, the literature reveals that primary radiotherapy can also achieve a remission of symptoms [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>] and given the fact that multicentric CD, more often then unicentric CD, causes generalised symptoms, radiotherapy could also be used as a symptomatic treatment.</p>
      <p>The rationale of our additional intra-operative radiotherapy (IORT) boost was based on the close relationship with the sacral bone and iliac vessels and was analogous to our management of other locally advanced solid tumours like rectal cancer and soft tissue sarcomas [<xref ref-type="bibr" rid="B37">37</xref>-<xref ref-type="bibr" rid="B40">40</xref>].</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In this case report it is demonstrated that neo-adjuvant radiotherapy in case of locally advanced irresectable unicentric CD facilitates a radical resection. Therefore, analogous with the treatment of other locally advanced solid tumours, neo-adjuvant radiotherapy with a dose of 40-50 Gy and a subsequent resection 6 weeks later should be considered if an irresectable unicentric variant of CD is encountered.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>IAC, MMS, GAP have made substantial contributions to conception and design, and acquisition of data and analysis and interpretation of data. IAC, MMS, T, MLM, JP, GAP have been involved in drafting the manuscript or revising it critically for important intellectual content. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Castleman</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Towne</surname>
            <given-names>VW</given-names>
          </name>
          <article-title>Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot</article-title>
          <source>N Engl J Med</source>
          <year>1954</year>
          <volume>251</volume>
          <issue>10</issue>
          <fpage>396</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="pmid">13194083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Castleman</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Iverson</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Menendez</surname>
            <given-names>VP</given-names>
          </name>
          <article-title>Localized mediastinal lymphnode hyperplasia resembling thymoma</article-title>
          <source>Cancer</source>
          <year>1956</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>822</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(195607/08)9:4&lt;822::AID-CNCR2820090430&gt;3.0.CO;2-4</pub-id>
          <pub-id pub-id-type="pmid">13356266</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="book">
          <name>
            <surname>Flendrig</surname>
            <given-names>J</given-names>
          </name>
          <source>Benign giant lymphoma: clinicopathologic correlation study</source>
          <year>1970</year>
          <publisher-name>Chicago: Yearbook Medical Publishers</publisher-name>
          <fpage>296</fpage>
          <lpage>299</lpage>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Keller</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Hochholzer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Castleman</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations</article-title>
          <source>Cancer</source>
          <year>1972</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>670</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197203)29:3&lt;670::AID-CNCR2820290321&gt;3.0.CO;2-#</pub-id>
          <pub-id pub-id-type="pmid">4551306</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Casper</surname>
            <given-names>C</given-names>
          </name>
          <article-title>The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care</article-title>
          <source>Br J Haematol</source>
          <year>2005</year>
          <volume>129</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2141.2004.05311.x</pub-id>
          <pub-id pub-id-type="pmid">15801951</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>McCarty</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Vukelja</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Banks</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>RB</given-names>
          </name>
          <article-title>Angiofollicular lymph node hyperplasia (Castleman's disease)</article-title>
          <source>Cancer Treat Rev</source>
          <year>1995</year>
          <volume>21</volume>
          <issue>4</issue>
          <fpage>291</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="doi">10.1016/0305-7372(95)90034-9</pub-id>
          <pub-id pub-id-type="pmid">7585657</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dispenzieri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gertz</surname>
            <given-names>MA</given-names>
          </name>
          <article-title>Treatment of Castleman's disease</article-title>
          <source>Curr Treat Options Oncol</source>
          <year>2005</year>
          <volume>6</volume>
          <issue>3</issue>
          <fpage>255</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="doi">10.1007/s11864-005-0008-z</pub-id>
          <pub-id pub-id-type="pmid">15869736</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gaba</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Sweet</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Variakojis</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Multicentric giant lymph node hyperplasia</article-title>
          <source>Am J Clin Pathol</source>
          <year>1978</year>
          <volume>69</volume>
          <issue>1</issue>
          <fpage>86</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">619617</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bowne</surname>
            <given-names>WB</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Filippa</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Niesvizky</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Burt</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Brennan</surname>
            <given-names>MF</given-names>
          </name>
          <article-title>The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature</article-title>
          <source>Cancer</source>
          <year>1999</year>
          <volume>85</volume>
          <issue>3</issue>
          <fpage>706</fpage>
          <lpage>717</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19990201)85:3&lt;706::AID-CNCR21&gt;3.0.CO;2-7</pub-id>
          <pub-id pub-id-type="pmid">10091744</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chronowski</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Ha</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Wilder</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>Cabanillas</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Manning</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>JD</given-names>
          </name>
          <article-title>Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>92</volume>
          <issue>3</issue>
          <fpage>670</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20010801)92:3&lt;670::AID-CNCR1369&gt;3.0.CO;2-Q</pub-id>
          <pub-id pub-id-type="pmid">11505414</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Herrada</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cabanillas</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Rice</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Manning</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pugh</surname>
            <given-names>W</given-names>
          </name>
          <article-title>The clinical behavior of localized and multicentric Castleman disease</article-title>
          <source>Ann Intern Med</source>
          <year>1998</year>
          <volume>128</volume>
          <issue>8</issue>
          <fpage>657</fpage>
          <lpage>662</lpage>
          <pub-id pub-id-type="pmid">9537940</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Frizzera</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Castleman's disease: more questions than answers</article-title>
          <source>Hum Pathol</source>
          <year>1985</year>
          <volume>16</volume>
          <issue>3</issue>
          <fpage>202</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="doi">10.1016/S0046-8177(85)80002-2</pub-id>
          <pub-id pub-id-type="pmid">3871724</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Frizzera</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Castleman's disease and related disorders</article-title>
          <source>Semin Diagn Pathol</source>
          <year>1988</year>
          <volume>5</volume>
          <issue>4</issue>
          <fpage>346</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">2464187</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Humphreys</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Holley</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>McIlrath</surname>
            <given-names>DC</given-names>
          </name>
          <article-title>Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephroitc syndrome</article-title>
          <source>Mayo Clin Proc</source>
          <year>1975</year>
          <volume>50</volume>
          <issue>6</issue>
          <fpage>317</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="pmid">1127997</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>LeVan</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Clifford</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Staren</surname>
            <given-names>ED</given-names>
          </name>
          <article-title>Castleman's tumor masquerading as a pancreatic neoplasm</article-title>
          <source>Surgery</source>
          <year>1989</year>
          <volume>106</volume>
          <issue>5</issue>
          <fpage>884</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="pmid">2683174</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Menke</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Camoriano</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Banks</surname>
            <given-names>PM</given-names>
          </name>
          <article-title>Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis</article-title>
          <source>Mod Pathol</source>
          <year>1992</year>
          <volume>5</volume>
          <issue>5</issue>
          <fpage>525</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">1285353</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Seco</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Velasco</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Manuel</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Tomas</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Velasco</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Retroperitoneal Castleman's disease</article-title>
          <source>Surgery</source>
          <year>1992</year>
          <volume>112</volume>
          <issue>5</issue>
          <fpage>850</fpage>
          <lpage>855</lpage>
          <pub-id pub-id-type="pmid">1440235</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shahidi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Kvale</surname>
            <given-names>PA</given-names>
          </name>
          <article-title>Castleman's disease</article-title>
          <source>Mayo Clin Proc</source>
          <year>1995</year>
          <volume>70</volume>
          <issue>10</issue>
          <fpage>969</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="doi">10.4065/70.10.969</pub-id>
          <pub-id pub-id-type="pmid">7564550</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shroff</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Gilchrist</surname>
            <given-names>BF</given-names>
          </name>
          <name>
            <surname>DeLuca</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>McCombs</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Wesselhoeft</surname>
            <given-names>CW</given-names>
          </name>
          <article-title>Castleman's disease presenting as a pediatric surgical problem</article-title>
          <source>J Pediatr Surg</source>
          <year>1995</year>
          <volume>30</volume>
          <issue>5</issue>
          <fpage>745</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-3468(95)90707-6</pub-id>
          <pub-id pub-id-type="pmid">7623245</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Martino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cariati</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tintisona</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Veneroso</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>De Villa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Vergine</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Monti</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Atypical lymphoproliferative disorders: Castleman's disease. Case report and review of the literature</article-title>
          <source>Tumori</source>
          <year>2004</year>
          <volume>90</volume>
          <issue>3</issue>
          <fpage>352</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">15315321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gittinger</surname>
            <given-names>JW</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Ocular involvement in Castleman's disease. Response to radiotherapy</article-title>
          <source>Ophthalmology</source>
          <year>1989</year>
          <volume>96</volume>
          <issue>11</issue>
          <fpage>1646</fpage>
          <lpage>1649</lpage>
          <pub-id pub-id-type="pmid">2616150</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Latz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Schraube</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rieden</surname>
            <given-names>K</given-names>
          </name>
          <article-title>[The radiotherapy of Castleman's lymphoma]</article-title>
          <source>Strahlenther Onkol</source>
          <year>1992</year>
          <volume>168</volume>
          <issue>5</issue>
          <fpage>297</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="pmid">1598666</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Marti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pahissa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Guardia</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Moragas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bacardi</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>51</volume>
          <issue>5</issue>
          <fpage>808</fpage>
          <lpage>810</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19830301)51:5&lt;808::AID-CNCR2820510510&gt;3.0.CO;2-5</pub-id>
          <pub-id pub-id-type="pmid">6821846</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Massey</surname>
            <given-names>GV</given-names>
          </name>
          <name>
            <surname>Kornstein</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Wahl</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>XL</given-names>
          </name>
          <name>
            <surname>McCrady</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Carchman</surname>
            <given-names>RA</given-names>
          </name>
          <article-title>Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings</article-title>
          <source>Cancer</source>
          <year>1991</year>
          <volume>68</volume>
          <issue>6</issue>
          <fpage>1365</fpage>
          <lpage>1372</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19910915)68:6&lt;1365::AID-CNCR2820680630&gt;3.0.CO;2-Q</pub-id>
          <pub-id pub-id-type="pmid">1873789</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Neuhof</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Debus</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Outcome and late complications of radiotherapy in patients with unicentric Castleman disease</article-title>
          <source>Acta Oncol</source>
          <year>2006</year>
          <volume>45</volume>
          <issue>8</issue>
          <fpage>1126</fpage>
          <lpage>1131</lpage>
          <pub-id pub-id-type="doi">10.1080/02841860600812701</pub-id>
          <pub-id pub-id-type="pmid">17118850</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nordstrom</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Tewfik</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Latourette</surname>
            <given-names>HB</given-names>
          </name>
          <article-title>Giant lymph node hyperplasia: a review of literature and report of two cases of plasma cell variant responding to radiation therapy</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>1978</year>
          <volume>4</volume>
          <issue>11-12</issue>
          <fpage>1045</fpage>
          <lpage>1048</lpage>
          <pub-id pub-id-type="pmid">102620</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sethi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>BD</given-names>
          </name>
          <article-title>Radiation therapy in the management of giant lymph node hyperplasia</article-title>
          <source>Br J Radiol</source>
          <year>1990</year>
          <volume>63</volume>
          <issue>752</issue>
          <fpage>648</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1259/0007-1285-63-752-648</pub-id>
          <pub-id pub-id-type="pmid">2400884</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stokes</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Griffith</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>PR</given-names>
          </name>
          <article-title>Angiofollicular lymph node hyperplasia (Castleman's disease) associated with vertebral destruction</article-title>
          <source>Cancer</source>
          <year>1985</year>
          <volume>56</volume>
          <issue>4</issue>
          <fpage>876</fpage>
          <lpage>879</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19850815)56:4&lt;876::AID-CNCR2820560429&gt;3.0.CO;2-C</pub-id>
          <pub-id pub-id-type="pmid">4016679</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Veldhuis</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Leest</surname>
            <given-names>AH van der</given-names>
          </name>
          <name>
            <surname>de Wolf</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>de Vries</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Vellenga</surname>
            <given-names>E</given-names>
          </name>
          <article-title>A case of localized Castleman's disease with systemic involvement: treatment and pathogenetic aspects</article-title>
          <source>Ann Hematol</source>
          <year>1996</year>
          <volume>73</volume>
          <issue>1</issue>
          <fpage>47</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1007/s002770050201</pub-id>
          <pub-id pub-id-type="pmid">8695726</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Weisenburger</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>DeGowin</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Armitage</surname>
            <given-names>JO</given-names>
          </name>
          <article-title>Remission of giant lymph node hyperplasia with anemia after radiotherapy</article-title>
          <source>Cancer</source>
          <year>1979</year>
          <volume>44</volume>
          <issue>2</issue>
          <fpage>457</fpage>
          <lpage>462</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197908)44:2&lt;457::AID-CNCR2820440212&gt;3.0.CO;2-4</pub-id>
          <pub-id pub-id-type="pmid">476562</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dispenzieri</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Castleman disease</article-title>
          <source>Cancer Treat Res</source>
          <year>2008</year>
          <volume>142</volume>
          <fpage>293</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">18283792</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nordstrom</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Tewfik</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Latourette</surname>
            <given-names>HB</given-names>
          </name>
          <article-title>Plasma cell giant lymph node hyperplasia responding to radiation therapy</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>1978</year>
          <volume>130</volume>
          <issue>1</issue>
          <fpage>169</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">413407</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yoshida</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sakata</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawai</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kayano</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hirashima</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Matsutani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bessho</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Successful treatment of multicentric Castleman's disease with intracranial and retroperitoneal tumors</article-title>
          <source>Intern Med</source>
          <year>2001</year>
          <volume>40</volume>
          <issue>9</issue>
          <fpage>976</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.40.976</pub-id>
          <pub-id pub-id-type="pmid">11579970</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Emson</surname>
            <given-names>HE</given-names>
          </name>
          <article-title>Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis</article-title>
          <source>Cancer</source>
          <year>1973</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>241</fpage>
          <lpage>245</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197301)31:1&lt;241::AID-CNCR2820310132&gt;3.0.CO;2-T</pub-id>
          <pub-id pub-id-type="pmid">4683040</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fitzpatrick</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>TC</given-names>
          </name>
          <article-title>Angiofollicular lymph node hyperplasia</article-title>
          <source>Can Med Assoc J</source>
          <year>1968</year>
          <volume>99</volume>
          <issue>25</issue>
          <fpage>1259</fpage>
          <lpage>1262</lpage>
          <pub-id pub-id-type="pmid">5700853</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lim</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Jeong</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>DY</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JG</given-names>
          </name>
          <article-title>Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers</article-title>
          <source>Ann Surg</source>
          <year>2008</year>
          <volume>248</volume>
          <issue>2</issue>
          <fpage>243</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="doi">10.1097/SLA.0b013e31817fc2a0</pub-id>
          <pub-id pub-id-type="pmid">18650634</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sadahiro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ishikawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yasuda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tajima</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Makuuchi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Murayama</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ohizumi</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Intraoperative radiation therapy for curatively resected rectal cancer</article-title>
          <source>Dis Colon Rectum</source>
          <year>2001</year>
          <volume>44</volume>
          <issue>11</issue>
          <fpage>1689</fpage>
          <lpage>1695</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02234391</pub-id>
          <pub-id pub-id-type="pmid">11711743</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stitzenberg</surname>
            <given-names>KB</given-names>
          </name>
          <name>
            <surname>Klauber-Demore</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>XS</given-names>
          </name>
          <name>
            <surname>Calvo</surname>
            <given-names>BF</given-names>
          </name>
          <name>
            <surname>Ollila</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Goyal</surname>
            <given-names>LK</given-names>
          </name>
          <name>
            <surname>Meyers</surname>
            <given-names>MO</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Tepper</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Sartor</surname>
            <given-names>CI</given-names>
          </name>
          <article-title>In vivo intraoperative radiotherapy: a novel approach to radiotherapy for early stage breast cancer</article-title>
          <source>Ann Surg Oncol</source>
          <year>2007</year>
          <volume>14</volume>
          <issue>4</issue>
          <fpage>1515</fpage>
          <lpage>1516</lpage>
          <pub-id pub-id-type="doi">10.1245/s10434-006-9152-3</pub-id>
          <pub-id pub-id-type="pmid">17235715</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willett</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Suit</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Tepper</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Mankin</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Convery</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>WC</given-names>
          </name>
          <article-title>Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma</article-title>
          <source>Cancer</source>
          <year>1991</year>
          <volume>68</volume>
          <issue>2</issue>
          <fpage>278</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19910715)68:2&lt;278::AID-CNCR2820680211&gt;3.0.CO;2-C</pub-id>
          <pub-id pub-id-type="pmid">1906369</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Willett</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Czito</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Tyler</surname>
            <given-names>DS</given-names>
          </name>
          <article-title>Intraoperative radiation therapy</article-title>
          <source>J Clin Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <issue>8</issue>
          <fpage>971</fpage>
          <lpage>977</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2006.10.0255</pub-id>
          <pub-id pub-id-type="pmid">17350946</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
